BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 4, 2012
View Archived Issues
Cross-strain neutralizing malaria vaccines evaluated in preclinical study
Read More
Pathogen-specific R-type pyocin may hold promise to treat EHEC infections
Read More
Naturally occurring antiobesity agent mimics calorie restriction in patients with obesity
Read More
Phase II study investigates effects of ganetespib in subjects with breast cancer
Read More
New metabotropic glutamate mGlu5 receptor antagonists prepared by GlaxoSmithKline
Read More
Novel TNF-alpha production inhibitors presented by scientists in China
Read More
Novel tyrosine-protein kinase BTK inhibitors disclosed by Ono Pharmaceutical
Read More
Dainippon Sumitomo Pharma synthesizes new Toll-like receptor antagonists
Read More
New free fatty acid FFA2 receptor agonists/partial agonists reported by Euroscreen
Read More
New acetyl-L-carnitine salt prepared in Korea
Read More
Bayer Schering Pharma presents new protein kinase inhibitors
Read More
Interim data presented from phase I/II trial of neratinib plus capecitabine in breast cancer
Read More
Osiris reports on phase II trial of Prochymal
Read More
Generex provides update on second-generation peptide vaccine for cancer
Read More
Ikaria begins registration trial of bioabsorbable matrix for use after heart attack
Read More
SNS01-T shows synergy with lenalidomide in human cancer model
Read More
BioMarin's IND for achondroplasia therapy is active
Read More
Ampio Pharmaceuticals completes expanded enrollment in Ampion trial
Read More
Gene therapy for hemophilia B granted orphan drug status by FDA
Read More
Yakult Honsha begins phase I/II study of perifosine in Japan
Read More
Phase I/II CF-102 trials meet primary endpoints
Read More
MacuCLEAR raises funds and enters partnership for lead AMD treatment
Read More
BioMimetic Therapeutics receives response to Augment Bone Graft PMA
Read More
FDA approves label expansion for CSL Behring's Berinert
Read More
BioMimetic obtains CE mark for growth factor-enhanced matrix
Read More